Table 1.

Sequences of oligonucleotides used for EMSAs and site-directed mutagenesis. The 5′ overhangs are marked in blue, the core hypoxia responsive elements are underlined and the introduced mutations are marked in red. The reverse complementary oligonucleotides are not shown